Cadnapaphornchai P, Kellner D, McDonald F D
Proc Soc Exp Biol Med. 1987 May;185(1):24-30. doi: 10.3181/00379727-185-42511.
We evaluated the role of intracellular calcium in renal nerve-mediated renin release in four groups of anesthetized dogs. Each dog received renal nerve stimulation (RNS)(0.5 Hz) twice as follow: control, RNS, recovery; control, RNS, recovery. Group 1 served as time control. Group 2 received Ca ionophore A23187 (Io) and Groups 3 and 4 received verapamil at 2.5 and 5 micrograms/kg X min respectively during the second RNS. In Group 1, renin secretion rate (RSR) increased from 95 +/- 22 to 223 +/- 73 (P less than 0.05) and from 13 +/- 5 to 108 +/- 20 ngANG I/hr X min (P less than 0.005) during the first and second RNS, respectively. In Group 2, RSR increased from 210 +/- 85 to 402 +/- 118 (P less than 0.02) and from 88 +/- 11 to 157 +/- 39 ngANG I/hr X min (NS) during the first and second RNS, respectively. In both groups, systemic and renal hemodynamics and UNaV did not change. In Group 3, verapamil alone did not increase RSR. During RNS, RSR also did not increase. In Group 4, verapamil alone increased RSR from 42 +/- 12 to 273 +/- 71 ngANG I/hr X min (P less than 0.03) despite a similar reduction in systemic blood pressure as in Group 3. RNS did not increase RSR further during verapamil infusion. The present study suggests that increased intracellular Ca by Io inhibits renal nerve-mediated renin release. A low dose of verapamil has no effect on renin release and does not augment renal nerve-mediated renin release. A high dose of verapamil increases renin release but does not enhance RNS-mediated renin release. We conclude that intracellular calcium plays an important role in renin release and may be the final messenger in renal nerve-mediated renin release.
我们在四组麻醉犬中评估了细胞内钙在肾神经介导的肾素释放中的作用。每只犬接受两次肾神经刺激(RNS)(0.5赫兹),如下所示:对照组、RNS组、恢复组;对照组、RNS组、恢复组。第1组作为时间对照组。第2组在第二次RNS期间接受钙离子载体A23187(Io),第3组和第4组在第二次RNS期间分别以2.5和5微克/千克×分钟的剂量接受维拉帕米。在第1组中,第一次和第二次RNS期间肾素分泌率(RSR)分别从95±22增加到223±73(P<0.05)和从13±5增加到108±20纳克血管紧张素I/小时×分钟(P<0.005)。在第2组中,第一次和第二次RNS期间RSR分别从210±85增加到402±118(P<0.02)和从88±11增加到157±39纳克血管紧张素I/小时×分钟(无统计学意义)。在两组中,全身和肾脏血流动力学以及尿钠排泄均未改变。在第3组中,单独使用维拉帕米未增加RSR。在RNS期间,RSR也未增加。在第4组中,尽管全身血压下降情况与第3组相似,但单独使用维拉帕米使RSR从42±12增加到273±71纳克血管紧张素I/小时×分钟(P<0.03)。在维拉帕米输注期间,RNS未进一步增加RSR。本研究表明,Io使细胞内钙增加可抑制肾神经介导的肾素释放。低剂量维拉帕米对肾素释放无影响,也不增强肾神经介导的肾素释放。高剂量维拉帕米可增加肾素释放,但不增强RNS介导的肾素释放。我们得出结论,细胞内钙在肾素释放中起重要作用,可能是肾神经介导的肾素释放中的最终信使。